Keymed Biosciences Inc. (HKG:2162)
Hong Kong · Delayed Price · Currency is HKD 72.50
-2.75 (-3.65%)
Jul 30, 2026, 3:40 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 22.17 billion as of July 29, 2026. Its market cap has increased by 19.26% in one year.
Market Cap
22.17B
Enterprise Value
20.91B
Revenue
797.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.50
ChartMarket Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 22.17B, an increase of 20.30%. That is a compound annual growth rate of 3.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 22.17B | 40.79% |
| Dec 31, 2025 | 15.75B | 84.90% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3SBio | 42.69B |
| Shanghai Junshi Biosciences | 36.60B |
| Genscript Biotech | 35.23B |
| Shanghai Henlius Biotech | 30.44B |
| InnoCare Pharma | 28.49B |
| Duality Biotherapeutics | 20.56B |
| Zai Lab | 16.93B |
| Metis TechBio | 13.31B |